-
CarlsonTeke2 posted an update in the group Multiple Sclerosis Advocate Network
A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic Setting.
-
CarlsonTeke2 posted an update in the group Multiple Sclerosis Advocate Network
A study based at Johns Hopkins University is comparing two treatment strategies in 900 people newly diagnosed, or with onset/diagnosis in the past who have received minimal or no treatment, with the relapsing-remitting form of MS.
MS Trial Alert: Seeking People Newly Diagnosed or Untreated with Relapsing MS Nationwide to… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
Benzodiazepines are associated with increased risk of Alzheimer's disease — ScienceDailyThe use of benzodiazepines and related drugs (Z drugs) is associated with a modestly increased risk of Alzheimer’s disease, according to a recent study. -
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Approved Drugs for Alzheimer's Disease – Alzheimer's News TodayRead about the five prescription medicines approved by the FDA to treat Alzheimer’s symptoms that impact thinking and memory, and disease stages they treat. -
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Drugs in development for cancer may also fight brain diseases, including ALS: PARP inhibitors show promise in preventing toxic accumulations of brain disease proteins — ScienceDailyA class of cancer drugs called PARP inhibitors could be useful for… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
University College London analyzed trends in AD and dementias to see if there are any trends among different ethnicities but information also indicated that diagnosis differs. This reminds us that diagnoses aren’t an exact standard protocol but the best efforts put by our healthcare teams. We have to work together to continue the push for…[Read more]
-
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
This US-POINTER trial will test a 2-year multi-site and community-based multi domain intervention of physical activity, nutritional guidance, cognitive training and social activities, and management of medical co-morbidities for Alzheimer’s patients.
U.S. POINTER | Alzheimer's… -
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
new data from the SPRINT MIND trial is an exciting first in our understanding of how aggressively treating systolic blood pressure could be part of a solution to treat Alzheimer’s.
Dementia & Blood Pressure | Blog | Alzheimer's… -
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Previous studies have shown changes to the brain as early as 10 to 20 years before the symptoms of Alzheimer’s Disease arise, but this body-worn sensors may help detect onset of Alzheimer’s disease.
Gait assessed with body-worn sensors may help detect onset of Alzheimer’s disease | Journal of Alzheimer's Dis… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
MiR-132, a micro RNA, may another neuroprotective molecule that clinicians and researchers can utilize for treatment giving clinical teams more avenues to attack AD.
Newly characterized molecule offers possibilities for novel Alzheimer's treatments –… -
CarlsonTeke2 posted an update in the group Hypertension Advocate Network
Can spinal cord stimulation during exercise help with decreasing the impact of hypertension?
-
CarlsonTeke2 posted an update in the group Hypertension Advocate Network
This is a good research to keep an eye on.
-
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
The Alzheimer’s Prevention Registry is attempting to collect enough information to improve the diagnosis process for the future patients.
-
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Could this be the solution for Alzheimer’s Disease? =[L+MZ+Z+DHA+EPA] | Journal of Alzheimer's DiseaseShare Us: Subscribe | Contact -
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Deep Brain Stimulation showing promise for patients with mild Alzheimer’s disease over age 65 | Journal of Alzheimer's DiseaseShare Us: Subscribe | Contact -
CarlsonTeke2 posted an update in the group Hypertension Advocate Network
10 of the best blood pressure apps for 2017Blood pressure can be managed through apps that can track and monitor your levels and reduce your risk factors for developing high blood pressure. -
CarlsonTeke2 posted an update in the group Hypertension Advocate Network
Could magnesium regulate blood pressure?A new meta-analysis finds that a median dosage of 368 mg of magnesium daily may moderately reduce blood pressure in patients with high blood pressure. -
CarlsonTeke2 posted an update in the group Hypertension Advocate Network
Regular sauna use could slash men's hypertension riskThe risk of high blood pressure may be up to 46 percent lower for men who use a sauna at least twice weekly, a Finnish study suggests. -
CarlsonTeke2 posted an update in the group Hypertension Advocate Network
Death risk increased with two blood pressure drugsResearchers reveal that two classes of medication used to treat hypertension could raise blood pressure variability, which may increase the risk of death. -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
The potential dangers of the things that we often take granted like the air we breathe or in this case the water we drink, can be linked to brain damage that takes years to become clinically significant and therefore nearly impossible to pin down on. Animal research in Taiwan is indicating that ultrasound is a possible mitigator in protecting the…[Read more]
- Load More
